IC
BCRX icon

IEQ Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History

IEQ Capital’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Buy
+227,421
New +$2.06M 0.01% 760
2025
Q4 		– Sell
-71,950
Closed -$546K – 1867
2025
Q3 		$546K Sell
71,950
-52,433
-42% -$437K ﹤0.01% 1251
2025
Q2 		$1.11M Buy
124,383
+1,680
+1% +$15.6K 0.01% 822
2025
Q1 		$920K Buy
122,703
+93,267
+317% +$752K 0.01% 783
2024
Q4 		$221K Buy
+29,436
New +$223K ﹤0.01% 1162

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

IEQ Capital's BCRX Position: Q2 2026 in Review

IEQ Capital opened a new position in BioCryst Pharmaceuticals (BCRX) in Q2 2026: 227,421 shares worth $2.27M. The stake represents 0.01% of the portfolio and ranks #760 among its holdings. This is a return to the name: IEQ Capital previously reported a position in BCRX as recently as Q3 2025.

IEQ Capital first reported a position in BCRX in Q4 2024 and has held it in 5 quarters since. 319 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • IEQ Capital held 227,421 shares of BioCryst Pharmaceuticals worth $2.27M as of Q2 2026.
  • BioCryst Pharmaceuticals was a new IEQ Capital position in Q2 2026.
  • BioCryst Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #760 holding.
  • IEQ Capital first reported a position in BioCryst Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 319 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.